Acute pancreatitis induced by Tadalafil: a case report

  • Seyed Jafar Navabi
  • Mina Khosravifar
  • Seyed Mohammad Navabi
  • Ruhollah HeydariEmail author
Case Report


Acute pancreatitis is commonly caused by gallstones or alcohol abuse. Also, this complication has rarely been associated with other etiologies like drugs in some reports. We report the case of a 43-year-old man with 10-days history of taking Tadalafil for erectile dysfunction. The patient was presented to the emergency room with manifestations of acute pancreatitis. This diagnosis was confirmed after clinical examination, laboratory tests, and radiologic evaluation. Other probable etiological factors were ruled out. A total score of seven using Naranjo Adverse Drug Reaction Probability Scale clarifies a probable diagnosis of drug-induced acute pancreatitis in this case. The reported case of acute pancreatitis was most likely induced with Tadalafil.


Acute pancreatitis Tadalafil Erectile dysfunction Adverse drug reaction 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Human/animal Rights

This case report contains no intervention on human being and all of the informations are published with the patient’s consent

Informed consent

This case report reveals no personal data from the patient, although oral consent is taken from the patient.


  1. 1.
    Sarles H. Revised classification of pancreatitis—Marseille 1984. Dig Dis Sci. 1985;30:573–4.CrossRefGoogle Scholar
  2. 2.
    Granger J, Remick D. Acute pancreatitis: models, markers, and mediators. Shock. 2005;24:45–51.CrossRefGoogle Scholar
  3. 3.
    Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States:2012 update. Gastroenterology. 2012;143:1179–87.CrossRefGoogle Scholar
  4. 4.
    Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149:1731–41.CrossRefGoogle Scholar
  5. 5.
    Das S, Mahakkanukrauh P, Ho CC. The burden of gastrointestinal, liver, and pancreatic diseases: the global scenario. Gastroenterology. 2016;150:1045–6.CrossRefGoogle Scholar
  6. 6.
    Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterol-Orlando. 2007;132:2022–44.CrossRefGoogle Scholar
  7. 7.
    Yang AL, Vadhavkar S, Singh G, et al. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008;168:649–56.CrossRefGoogle Scholar
  8. 8.
    Bahú MD, Baldisseroto M, Custodio CM, et al. Hepatobiliary and pancreatic complications of ascariasis in children: a study of seven cases. J Pediatr Gastroenterol Nutr. 2001;33:271–5.CrossRefGoogle Scholar
  9. 9.
    Uomo G, Manes G, Ragozzino A, et al. Periampullary extraluminal duodenal diverticula and acute pancreatitis: an underestimated etiological association. Am J Gastroenterol. 1996;91:1186–8.PubMedGoogle Scholar
  10. 10.
    Pilleul F, Rochette A, Partensky C, et al. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging. 2005;21:237–44.CrossRefGoogle Scholar
  11. 11.
    Poruk KE, Griffin JF, Wolfgang CL, et al (2019) Pancreatic and periampullary cancer. In: Shackelford's surgery of the alimentary tract, Vol. 2. Content Repository Only! pp 1136–1148Google Scholar
  12. 12.
    Wang DB, Yu J, Fulcher AS, et al. Pancreatitis in patients with pancreas divisum: imaging features at MRI and MRCP. World J Gastroenterol. 2013;19:4907.CrossRefGoogle Scholar
  13. 13.
    Nitsche CJ, Jamieson N, Lerch MM, et al. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143–55.CrossRefGoogle Scholar
  14. 14.
    Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17:887–93.CrossRefGoogle Scholar
  15. 15.
    Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.CrossRefGoogle Scholar
  16. 16.
    Corbin J, Francis S. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract. 2001;56:453–9.Google Scholar
  17. 17.
    Porst H, Padma-Nathan H, Giuliano F, et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 2003;62:121–5.CrossRefGoogle Scholar
  18. 18.
    Porst H. IC351 (tadalafil, Cialis): update on clinical experience. Int J Impot Res. 2002;14:S57.CrossRefGoogle Scholar
  19. 19.
    Brock GB, McMahon CG, Chen K, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168:1332–6.CrossRefGoogle Scholar
  20. 20.
    Emmick J, Stuewe S, Mitchell M. Overview of the cardiovascular effects of tadalafil. Eur Heart J Suppl. 2002;4:H32–H47.CrossRefGoogle Scholar
  21. 21.
    Donatucci CF, Wong DG, Giuliano F, et al. Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Curr Med Res Opin. 2008;24:3383–92.CrossRefGoogle Scholar
  22. 22.
    Committee for Medicinal Products for Human Use. Cialis. London: European Medicines Agency; 2012. p. 29.Google Scholar
  23. 23.
    Cialis and pancreatitis- from FDA reports. eHealthMe. (2019)
  24. 24.
    Lankisch P, Dröge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995;37:565–7.CrossRefGoogle Scholar
  25. 25.
    Avraam C, Siomos K, Armenaka M, et al. Clarithromycin associated acute pancreatitis. Ann Gastroenterol. 2007;20(1):35–7.Google Scholar
  26. 26.
    McArthur KE. Drug-induced pancreatitis. Aliment Pharmacol Ther. 1996;10:23–38.CrossRefGoogle Scholar
  27. 27.
    Balani AR, Grendell JH. Drug-induced pancreatitis. Drug Saf. 2008;31:823–37.CrossRefGoogle Scholar
  28. 28.
    Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2019

Authors and Affiliations

  • Seyed Jafar Navabi
    • 1
    • 2
  • Mina Khosravifar
    • 2
  • Seyed Mohammad Navabi
    • 3
  • Ruhollah Heydari
    • 2
    • 4
    Email author
  1. 1.Clinical Research Development CenterImam Khomeini and Mohammad Kermanshahi Hospitals, Kermanshah University of Medical SciencesKermanshahIran
  2. 2.School of MedicineKermanshah University of Medical SciencesKermanshahIran
  3. 3.School of PharmacyKermanshah University of Medical SciencesKermanshahIran
  4. 4.Imam Khomeini HospitalKermanshahIran

Personalised recommendations